Description

ETOSHINE 120 MG

Indications

ETOSHINE 120 MG, containing the active ingredient etoricoxib, is primarily indicated for the management of pain and inflammation associated with various conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also used for the treatment of acute pain, including pain following dental surgery. ETOSHINE is particularly beneficial for patients who require long-term treatment for chronic pain conditions due to its efficacy in reducing inflammation and pain without the gastrointestinal side effects commonly associated with traditional non-steroidal anti-inflammatory drugs (NSAIDs).

Mechanism of Action

Etoricoxib is a selective inhibitor of cyclooxygenase-2 (COX-2), an enzyme responsible for the synthesis of prostaglandins, which are mediators of inflammation and pain. By selectively inhibiting COX-2, ETOSHINE reduces the production of these inflammatory mediators, leading to decreased pain and inflammation. Unlike non-selective NSAIDs, which inhibit both COX-1 and COX-2, ETOSHINE minimizes gastrointestinal irritation and ulceration, making it a preferable option for many patients.

Pharmacological Properties

ETOSHINE 120 MG is well absorbed following oral administration, with peak plasma concentrations typically reached within 1-3 hours. The drug exhibits a half-life of approximately 22 hours, allowing for once-daily dosing. It is extensively metabolized in the liver, primarily via cytochrome P450 enzymes, and its metabolites are excreted mainly in the urine. The pharmacokinetics of ETOSHINE can be influenced by factors such as age, liver function, and renal impairment, necessitating careful consideration of dosing in these populations.

Contraindications

ETOSHINE 120 MG is contraindicated in patients with a known hypersensitivity to etoricoxib or any of its components. It should not be used in individuals with a history of gastrointestinal bleeding or ulceration, severe hepatic impairment, or those who are pregnant or breastfeeding. Additionally, patients with significant cardiovascular disease or those at high risk for cardiovascular events should use ETOSHINE with caution, as COX-2 inhibitors have been associated with an increased risk of thrombotic events.

Side Effects

Common side effects associated with ETOSHINE 120 MG include headache, dizziness, and gastrointestinal disturbances such as nausea and abdominal pain. Serious adverse effects, although rare, may include cardiovascular events (such as myocardial infarction and stroke), renal impairment, and liver dysfunction. Patients should be monitored for any signs of adverse reactions, especially during the initial stages of treatment or when the dosage is adjusted.

Dosage and Administration

The recommended dosage of ETOSHINE 120 MG for adults is one tablet taken orally once daily. The dosage may be adjusted based on the severity of the condition being treated and the patient’s response to therapy. It is important for patients to follow their healthcare provider’s instructions regarding dosing and to not exceed the recommended dose. ETOSHINE can be taken with or without food, although taking it with food may help reduce gastrointestinal discomfort.

Interactions

ETOSHINE 120 MG may interact with other medications, which can alter its effectiveness or increase the risk of adverse effects. Notable drug interactions include anticoagulants (such as warfarin), other NSAIDs, and certain antihypertensives. Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs and supplements, to avoid potential interactions. Monitoring may be necessary when ETOSHINE is used concurrently with these agents.

Precautions

Before initiating treatment with ETOSHINE 120 MG, a thorough medical history should be taken to identify any contraindications or risk factors. Caution is advised in patients with a history of cardiovascular disease, hypertension, or renal impairment. Regular monitoring of blood pressure and renal function is recommended during treatment, especially in long-term use. Patients should also be advised to report any unusual symptoms or side effects promptly to their healthcare provider.

Clinical Studies

Clinical studies have demonstrated the efficacy of ETOSHINE 120 MG in reducing pain and improving function in patients with osteoarthritis and rheumatoid arthritis. In randomized controlled trials, ETOSHINE was shown to provide significant pain relief compared to placebo, with a favorable safety profile. Additionally, studies have indicated that ETOSHINE is effective in managing acute pain, such as postoperative pain, with rapid onset of action. These findings support the use of ETOSHINE as a valuable option in the management of pain and inflammation.

Conclusion

ETOSHINE 120 MG is a potent and effective medication for the management of pain and inflammation associated with various musculoskeletal disorders. Its selective inhibition of COX-2 provides significant therapeutic benefits while minimizing gastrointestinal side effects. However, careful consideration of contraindications, potential drug interactions, and patient-specific factors is essential to ensure safe and effective use. As with any medication, it is important for patients to engage in open communication with their healthcare providers to optimize treatment outcomes.